Imagine the ability to visualize and measure phenotypic changes at the subcellular level in disease-relevant cell-based assays, all in real time, and at the earliest stages of drug discovery. That’s the power of high content imaging (HCI) using multi-parametric techniques, a vital tool that can guide your discovery program to success.
This webinar examines the following components of high content imaging and why you should use them:
- How complex model systems using a variety of cells can improve translation to clinic
- The impact high content screening (HCS) has on identification of new drug targets or lead compounds
- Optimizing lead compounds using high content analysis (HCA)
We’ll also discuss a case study screening iPSC-derived neurons for modifiers of Alzheimer’s-related phenotypes in a scalable multi-parameter system.
Shushant Jain, PhD
Group Leader Discovery
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.